Haut - TAKO - Tiroler Arbeitskreis für Onkologie
Haut - TAKO - Tiroler Arbeitskreis für Onkologie
Haut - TAKO - Tiroler Arbeitskreis für Onkologie
Erfolgreiche ePaper selbst erstellen
Machen Sie aus Ihren PDF Publikationen ein blätterbares Flipbook mit unserer einzigartigen Google optimierten e-Paper Software.
Kapitel 5<br />
50<strong>Haut</strong>tumore Melanom<br />
Bichakjian CK, Lowe L, Lao CD, Sandler HM, Bradford CR, Johnson TM,<br />
Wong SL. Merkel cell carcinoma: critical review with guidelines for<br />
multidisciplinary management. Cancer, 2007 1;110:1-12.<br />
Feng H, Shuda M, Chang Y, Moore PS; Clonal integration of a polyomavirus<br />
in human Merkel cell carcinoma. Science. 2008 Feb 22;319(5866):1096<br />
100.<br />
Heute D, Kostron H, von Guggenberg E, Ingorokva S, Gabriel M,<br />
Dobrozemsky G, Stockhammer G, Virgolini IJ.; Response of recurrent<br />
highgrade glioma to treatment with (90)YDOTATOC. J Nucl Med. 2010<br />
Mar;51(3):397400.<br />
Lemos BD, Storer BE, Iyer JG, Phillips JL, Bichakjian CK, Fang LC, Johnson<br />
TM, Liegeois-Kwon NJ, Otley CC, Paulson KG, Ross MI, Yu SS, Zeitouni<br />
NC, Byrd DR, Sondak VK, Gershenwald JE, Sober AJ, Nghiem P;<br />
Pathologic nodal evaluation improves prognostic accuracy in Merkel cell<br />
carcinoma: analysis of 5823 cases as the basis of the first consensus<br />
staging system. J Am Acad Dermatol. 2010 Nov;63(5):75161.<br />
Meier G, Waldherr C, Herrmann R, Maecke H, Mueller-Brand J, Pless M.;<br />
Successful targeted radiotherapy with 90Y-DOTATOC in a patient with<br />
Merkel cell carcinoma. A Case Report. Oncology. 2004;66(2):1603.<br />
Breuninger H, Sebastian G, Garbe C (2005): Deutsche Leitlinie<br />
Dermatofibrosarcoma protuberans. In: Garbe C (Hrsg.) Interdisziplinäre<br />
Leitlinien zur Diagnostik und Behandlung von <strong>Haut</strong>tumoren. Georg<br />
Thieme Verlag, Stuttgart, New York pp62–68.<br />
Fletcher CD, Evans BJ, MacArtney JC, Smith N, Wilson Jones E, McKee<br />
PH. Dermatofibrosarcoma protuberans: a clinicopathological and<br />
immunohistochemical study with a review of the literature. Histopathology.<br />
1985;9:921-938.<br />
Hafner HM, Moehrle M, Eder S, Trilling B, Rocken M, Breuninger H.<br />
3DHistological evaluation of surgery in dermatofibrosarcoma protuberans<br />
and malignant fibrous histiocytoma: Differences in growth patterns and<br />
outcome. Eur J Surg Oncol. 2008;34:680-686.<br />
Kransdorf MJ, Meis Kindblom JM. Dermatofibrosarcoma protuberans:<br />
radiologic appearance. AJR Am J Roentgenol. 1994;163: 391-394.<br />
Marks LB, Suit HD, Rosenberg AE, Wood WC. Dermatofibrosarcoma<br />
protuberans treated with radiation therapy. Int J Radiat Oncol Biol Phys.<br />
1989;17: 379-384.<br />
McArthur GA, Demetri GD, van Oosterom A, Heinrich MC, Debiec-Tychter<br />
M, Corless CL, Nikolova, Dimitijevic S. Molecular and clinical analysis of<br />
locally advanced dermatofibrosarcoma protuberans treated with imatinib: